At AJ, we continue to grow and are moving to new offices!
At AJ | Alurralde Jasper, we continue to grow and have some big news: we are moving to a new office located in Roosevelt building II, at 1643 Franklin D. Roosevelt Street (Belgrano, CABA). We are saying goodbye to our classic office on Av. Callao, which has been our home for so many years and […]
Globant Gamer Experience: a multisensory event for video game fans
The world of gaming has evolved over the last four decades in such a way that it has changed the way we play and experience digital entertainment. To celebrate Gamer Day, Globant held the “Globant Gamer Experience”, an event that brought together video game lovers, prominent figures from the gaming world, and journalists to enjoy […]
Communication and leadership: Without risks we do not differentiate ourselves
by Matías AlurraldeAJ | Alurralde Jasper + Asoc. President In three decades, we have experienced at least four revolutions in our profession.From the 90s to the present day, communication has undergone greattransformations driven by technological and sociocultural changes. Theunidirectionality and centralized control of the mass media in the 80s. Then,interactivity with the birth of the internet […]
Communication coaching for leaders: prepare without sounding robotic, inspire without overacting
When a leader manages to combine clarity, emotion, and purpose, communication can lead to action. by Mariana JasperPartner de AJ | Alurralde Jasper + Asoc. Effective communication requires us to meet three key criteria: be brief, be understood, and elicit behavior. We need to be heard, we want what we are trying to convey to […]
The National Administration of Medicines, Food and Medical Technology (ANMAT) approves nirsevimab to protect babies against bronchiolitis in Argentina.
Nirsevimab is the first immunization approved for the prevention of Respiratory Syncytial Virus (RSV) designed to be given to all infants. RSV is the leading cause of bronchiolitis in infants under one year of age. Following the approval of the European Commission and the U.S. Food and Drug Administration (FDA), the National Administration of […]
Tupperware® introduces its “Pink October” Set to support Breast Cancer Awareness Month through a partnership with LALCEC
In the month of October, in Campaigns 16 and 17 proposals, for each purchase of the set that includes the “Eco Twist” bottle and the “Good Vibes Only” Poeme, Tupperware® will collaborate in the donation of mammograms for women across the country. Buenos Aires, September 2023 – Tupperware joins Breast Cancer Awareness Month through an […]
World Breastfeeding Week: the challenge of facilitating Breastfeeding and Work for all families
World Breastfeeding Week is celebrated annually in the first week of August and this year the theme focuses on supporting effective practices to support breastfeeding in the workplace. In addition, measures that facilitate breastfeeding will be promoted, making a difference for working mothers and fathers. Specialists from the Otamendi Sanatorium explain the benefits of breastfeeding. […]
Total Austral will invest more than USD 100 million in Argentina over the next three years to achieve an 80% reduction in methane emissions
TotalEnergies, a multi-energy company that works to responsibly boost the supply of energy with lower emissions, will invest through Total Austral more than 100 million US dollars in the next three years to reach 80% in the reduction of methane emissions in Argentina. The company has already achieved a 60% reduction in methane emissions in […]
Mercedes-Benz EQA, a new generation
Mercedes-Benz Argentina presents the new EQA 350 4MATIC, the first 100% electric SUV of the brand to arrive in the country. This launch represents a historic event that will be marked as another milestone in the company’s trajectory. The vehicle is a compact SUV and has a close “kinship” with the GLA in terms of […]
The U.S. Food and Drug Administration (FDA) Advisory Committee unanimously recommends nirsevimab as the first immunization against RSV disease for all infants
Nirsevimab would be the first immunization specifically designed to protect all infants during their first RSV season, if approved. In all clinical trials, a single dose of nirsevimab demonstrated consistent and sustained high efficacy as well as favorable safety against RSV disease. The FDA has indicated that it will work to expedite its review. The […]